Publications by authors named "Bryan Mogle"

Claim this Profile
C
Comparison of vancomycin area under the concentration-time curve (AUC) using two-point pharmacokinetics versus two open-access online single-concentration vancomycin calculators.
Nicole M Ondrush, Rejs Ademovic, Robert W Seabury, William Darko, Christopher D Miller, Bryan T Mogle

J Clin Pharm Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost comparison of AUC:MIC- versus trough-based vancomycin monitoring for MRSA bacteremia.
Mario V Beccari, Robert W Seabury, Bryan T Mogle, Wesley D Kufel, Christopher D Miller

J Am Pharm Assoc (2003)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single-center cost analysis assessing a change in vasopressin formulation.
Courtney E Kelly, Christopher Miller, William Darko, Greg Cwikla, Bryan Mogle

Am J Health Syst Pharm· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo pharmacokinetic analysis of meropenem/vaborbactam during continuous venovenous haemodialysis.
Wesley D Kufel, Ambika P Eranki, Kristopher M Paolino, Andrea Call, Christopher D Miller, Bryan T Mogle

J Antimicrob Chemother· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibalizumab, a Novel Monoclonal Antibody for the Management of Multidrug-Resistant HIV-1 Infection.
Mario V Beccari, Bryan T Mogle, Eric F Sidman, Keri A Mastro, Elizabeth Asiago-Reddy

Antimicrob Agents Chemother· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical considerations for oral beta-lactams as step-down therapy for Enterobacteriaceae bloodstream infections.
Bryan T Mogle, Mario V Beccari, Jeffrey M Steele, Tasaduq Fazili, Wesley D Kufel

Expert Opin Pharmacother· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Readiness to implement vancomycin monitoring based on area under the concentration-time curve: A cross-sectional survey of a national health consortium.
Wesley D Kufel, Robert W Seabury, Bryan T Mogle, Mario V Beccari, Luke A Probst

Am J Health Syst Pharm· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Culture of Carbapenem Overconsumption: Where Does It Begin? Results of a Single-Center Survey.
Bryan T Mogle, Robert W Seabury, Zachary Jones, Christopher D Miller, Jeffrey M Steele

Hosp Pharm· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
Bryan T Mogle, Jeffrey M Steele, Robert W Seabury, Utkarsh J Dang, Wesley D Kufel

Int J Antimicrob Agents· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between prothrombin time and bleeding in hospitalized patients receiving rivaroxaban.
Ashley E Woodruff, Margaret M Wovkulich, Bryan T Mogle, Amany K Hassan

Am J Health Syst Pharm· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical review of delafloxacin: a novel anionic fluoroquinolone.
Bryan T Mogle, Jeffrey M Steele, Stephen J Thomas, KarenBeth H Bohan, Wesley D Kufel

J Antimicrob Chemother· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe neutrophilic dermatosis following submental deoxycholic acid administration.
Bryan T Mogle, Robert W Seabury, Shane Jennings, Gregory M Cwikla

Clin Toxicol (Phila)· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis